365 related articles for article (PubMed ID: 10662999)
21. Targeting immune cell circuits and trafficking in inflammatory bowel disease.
Neurath MF
Nat Immunol; 2019 Aug; 20(8):970-979. PubMed ID: 31235952
[TBL] [Abstract][Full Text] [Related]
22. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
23. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
24. NFAM1 Promotes Pro-Inflammatory Cytokine Production in Mouse and Human Monocytes.
Juchem KW; Gounder AP; Gao JP; Seccareccia E; Yeddula N; Huffmaster NJ; Côté-Martin A; Fogal SE; Souza D; Wang SS; Glynn ERA; Yung I; Ritchie J; Li L; Zheng J; Mbow ML; Li J; Chanda SK
Front Immunol; 2021; 12():773445. PubMed ID: 35095847
[TBL] [Abstract][Full Text] [Related]
25. IBD immunopathogenesis: A comprehensive review of inflammatory molecules.
Park JH; Peyrin-Biroulet L; Eisenhut M; Shin JI
Autoimmun Rev; 2017 Apr; 16(4):416-426. PubMed ID: 28212924
[TBL] [Abstract][Full Text] [Related]
26. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
27. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
Madsen JR
Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
[TBL] [Abstract][Full Text] [Related]
28. Recent developments in the immunology of inflammatory bowel disease.
MacDonald TT; Monteleone G; Pender SL
Scand J Immunol; 2000 Jan; 51(1):2-9. PubMed ID: 10632969
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of interleukin 17 in inflammatory bowel disease.
Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
[TBL] [Abstract][Full Text] [Related]
31. [Polygenetic disturbance in the front line mucosa defense].
Söderholm JD; Pettersson S
Lakartidningen; 2009 Nov 4-12; 106(45):2974, 2976-8. PubMed ID: 19998821
[No Abstract] [Full Text] [Related]
32. Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions.
Panés J
Acta Physiol Scand; 2001 Sep; 173(1):159-65. PubMed ID: 11678739
[TBL] [Abstract][Full Text] [Related]
33. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
34. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
35. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
[TBL] [Abstract][Full Text] [Related]
36. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.
Nakamura K; Honda K; Mizutani T; Akiho H; Harada N
World J Gastroenterol; 2006 Aug; 12(29):4628-35. PubMed ID: 16937430
[TBL] [Abstract][Full Text] [Related]
37. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions.
Dionne S; Ruemmele FM; Seidman EG
Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():41-57; discussion 58-61. PubMed ID: 11490627
[No Abstract] [Full Text] [Related]
38. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
39. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
40. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
